{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:52:25Z","timestamp":1774443145161,"version":"3.50.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40864-1","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:59:49Z","timestamp":1771477189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma lipid remodeling during the early recovery phase after myocardial infarction"],"prefix":"10.1038","volume":"16","author":[{"given":"Marcin","family":"Myszko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Bychowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Radziwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Skrzydlewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"\u0141uczaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"40864_CR1","unstructured":"World Health Organization. World Health Statistics 2024: Monitoring Health for the SDGs, Sustainable Development Goals. (2024). https:\/\/iris.who.int\/bitstream\/handle\/10665\/376869\/9789240094703-eng.pdf?sequence=1"},{"key":"40864_CR2","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.3390\/ijms22083850","volume":"22","author":"DJ Medina-Leyte","year":"2021","unstructured":"Medina-Leyte, D. J. et al. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int. J. Mol. Sci. 22, 3850 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"40864_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/antiox14030275","volume":"14","author":"M Myszko","year":"2025","unstructured":"Myszko, M., Bychowski, J., Skrzydlewska, E. & \u0141uczaj, W. The dual role of oxidative stress in atherosclerosis and coronary artery disease: Pathological mechanisms and diagnostic potential. Antioxidants 14, 275 (2025).","journal-title":"Antioxidants"},{"key":"40864_CR4","first-page":"101037","volume":"27","author":"JF Montero-Bullon","year":"2021","unstructured":"Montero-Bullon, J. F. et al. Cardiac phospholipidome is altered during ischemia and reperfusion in an ex vivo rat model. Biochem. Biophys. Rep. 27, 101037 (2021).","journal-title":"Biochem. Biophys. Rep."},{"key":"40864_CR5","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.3390\/ijms22094908","volume":"22","author":"T Paavola","year":"2021","unstructured":"Paavola, T. et al. Distinct fatty acid compositions of HDL phospholipids are characteristic of metabolic syndrome and premature coronary heart disease-family study. Int. J. Mol. Sci. 22, 4908 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"40864_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","volume":"81","author":"B Wang","year":"2019","unstructured":"Wang, B. & Tontonoz, P. Phospholipid remodeling in physiology and disease. Annu. Rev. Physiol. 81, 165\u2013188 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"40864_CR7","doi-asserted-by":"publisher","first-page":"8360","DOI":"10.3390\/ijms24098360","volume":"24","author":"DV Pistritu","year":"2023","unstructured":"Pistritu, D. V. et al. Phospholipids, the masters in the shadows during healing after acute myocardial infarction. Int. J. Mol. Sci. 24, 8360 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"40864_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.athplu.2023.12.001","volume":"55","author":"M Ponnaiah","year":"2023","unstructured":"Ponnaiah, M. et al. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. Atheroscler Plus. 55, 21\u201330 (2023).","journal-title":"Atheroscler Plus"},{"key":"40864_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12944-023-01832-0","volume":"22","author":"J Rong","year":"2023","unstructured":"Rong, J., He, T., Zhang, J., Bai, Z. & Shi, B. Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure. Lipids Health Dis. 22, 66 (2023).","journal-title":"Lipids Health Dis."},{"key":"40864_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang, M. et al. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Sig Transduct. Target. Ther. 9, 12 (2024).","journal-title":"Sig Transduct. Target. Ther."},{"key":"40864_CR11","doi-asserted-by":"publisher","first-page":"103751","DOI":"10.1016\/j.drudis.2023.103751","volume":"28","author":"G Astarita","year":"2023","unstructured":"Astarita, G., Kelly, R. S. & Lasky-Su, J. Metabolomics and lipidomics strategies in modern drug discovery and development. Drug Discov Today. 28, 103751 (2023).","journal-title":"Drug Discov Today"},{"key":"40864_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","volume":"41","author":"M Hilvo","year":"2020","unstructured":"Hilvo, M. et al. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. Eur. Heart J. 41, 371\u2013380 (2020).","journal-title":"Eur. Heart J."},{"key":"40864_CR13","doi-asserted-by":"publisher","first-page":"e121326","DOI":"10.1172\/jci.insight.121326","volume":"3","author":"PA Mundra","year":"2018","unstructured":"Mundra, P. A. et al. Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention. JCI Insight. 3, e121326\u2013e121326 (2018).","journal-title":"JCI Insight"},{"key":"40864_CR14","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1038\/s41598-022-09225-6","volume":"12","author":"N Timmerman","year":"2022","unstructured":"Timmerman, N. et al. Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy. Sci. Rep. 12, 5521 (2022).","journal-title":"Sci. Rep."},{"key":"40864_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11883-025-01284-0","volume":"27","author":"MK Campbell","year":"2025","unstructured":"Campbell, M. K., Chew, N. W. S. & Mehta, A. Beyond Cholesterol: Unraveling Residual Lipidomic Risk in Cardiovascular Health. Curr. Atheroscler Rep. 27, 37 (2025).","journal-title":"Curr. Atheroscler Rep."},{"key":"40864_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"40864_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0003-2697(70)90343-X","volume":"36","author":"EM Bartlett","year":"1970","unstructured":"Bartlett, E. M. & Lewis, D. H. Spectrophotometric determination of phosphate esters in the presence and absence of orthophosphate. Anal. Biochem. 36, 159\u2013167 (1970).","journal-title":"Anal. Biochem."},{"key":"40864_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.abb.2018.07.021","volume":"654","author":"W \u0141uczaj","year":"2018","unstructured":"\u0141uczaj, W. et al. Plasma lipidomic profile signature of rheumatoid arthritis versus Lyme arthritis patients. Arch. Biochem. Biophys. 654, 105\u2013114 (2018).","journal-title":"Arch. Biochem. Biophys."},{"key":"40864_CR19","doi-asserted-by":"crossref","unstructured":"\u0141uczaj, W., Wro\u0144ski, A., Domingues, P., Domingues, M. R. & Skrzydlewska, E. Lipidomic Analysis Reveals Specific Differences between Fibroblast and Keratinocyte Ceramide Profile of Patients with Psoriasis Vulgaris. Molecules 25, (2020).","DOI":"10.3390\/molecules25030630"},{"key":"40864_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A. & Ore\u0161i\u010d, M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform. 11, 395 (2010).","journal-title":"BMC Bioinform."},{"key":"40864_CR21","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52, W398\u2013W406 (2024).","journal-title":"Nucleic Acids Res."},{"key":"40864_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0163-7827(01)00003-0","volume":"40","author":"N Nagan","year":"2001","unstructured":"Nagan, N. & Zoeller, R. A. Plasmalogens: biosynthesis and functions. Prog Lipid Res. 40, 199\u2013229 (2001).","journal-title":"Prog Lipid Res."},{"key":"40864_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2016.01.003","volume":"246","author":"I Sutter","year":"2016","unstructured":"Sutter, I. et al. Decreased phosphatidylcholine plasmalogens\u2013A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction. Atherosclerosis 246, 130\u2013140 (2016).","journal-title":"Atherosclerosis"},{"key":"40864_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.atherosclerosis.2015.05.037","volume":"241","author":"I Sutter","year":"2015","unstructured":"Sutter, I. et al. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL. Atherosclerosis 241, 539\u2013546 (2015).","journal-title":"Atherosclerosis"},{"key":"40864_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.redox.2017.04.032","volume":"12","author":"J Lu","year":"2017","unstructured":"Lu, J. et al. Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases. Redox Biol. 12, 899\u2013907 (2017).","journal-title":"Redox Biol."},{"key":"40864_CR26","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.bbamem.2012.02.002","volume":"1818","author":"A Reis","year":"2012","unstructured":"Reis, A. & Spickett, C. M. Chemistry of phospholipid oxidation. Biochim. Biophys. Acta. 1818, 2374\u20132387 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"40864_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/ijms19020417","volume":"19","author":"T Zhou","year":"2018","unstructured":"Zhou, T., Prather, E. R., Garrison, D. E. & Zuo, L. Interplay between ROS and antioxidants during ischemia-reperfusion injuries in cardiac and skeletal muscle. Int. J. Mol. Sci. 19, 417 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"40864_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.atherosclerosis.2017.06.925","volume":"263","author":"JV Moxon","year":"2017","unstructured":"Moxon, J. V. et al. Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations. Atherosclerosis 263, 301\u2013308 (2017).","journal-title":"Atherosclerosis"},{"key":"40864_CR29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.mehy.2015.10.013","volume":"85","author":"OA Akerele","year":"2015","unstructured":"Akerele, O. A. & Cheema, S. K. Fatty acyl composition of lysophosphatidylcholine is important in atherosclerosis. Med. Hypotheses. 85, 754\u2013760 (2015).","journal-title":"Med. Hypotheses"},{"key":"40864_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1476-5381.2010.01117.x","volume":"162","author":"ND Hung","year":"2011","unstructured":"Hung, N. D., Kim, M. R. & Sok, D. E. Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis. Br. J. Pharmacol. 162, 1119\u20131135 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"40864_CR31","doi-asserted-by":"crossref","unstructured":"Kurian, G. A., Rajagopal, R., Vedantham, S. & Rajesh, M. The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: Revisited. Oxid Med Cell Longev 1656450 (2016). (2016).","DOI":"10.1155\/2016\/1656450"},{"key":"40864_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/15701611113119990003","volume":"13","author":"M Neri","year":"2015","unstructured":"Neri, M. et al. Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr. Vasc Pharmacol. 13, 26\u201336 (2015).","journal-title":"Curr. Vasc Pharmacol."},{"key":"40864_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1076029614531449","volume":"21","author":"NG Kounis","year":"2015","unstructured":"Kounis, N. G., Soufras, G. D., Tsigkas, G. & Hahalis, G. White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease. Clin. Appl. Thromb. Hemost. 21, 139\u2013143 (2015).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"40864_CR34","doi-asserted-by":"publisher","first-page":"12344","DOI":"10.1073\/pnas.1709228114","volume":"114","author":"A Chaudhury","year":"2017","unstructured":"Chaudhury, A., Noiret, L. & Higgins, J. M. White blood cell population dynamics for risk stratification of acute coronary syndrome. Proc. Natl. Acad. Sci. U S A. 114, 12344\u201312349 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"40864_CR35","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0735-1097(02)02484-1","volume":"40","author":"MS Sabatine","year":"2002","unstructured":"Sabatine, M. S. et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy. J. Am. Coll. Cardiol. 40, 1761\u20131768 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"40864_CR36","doi-asserted-by":"publisher","first-page":"118569","DOI":"10.1016\/j.atherosclerosis.2024.118569","volume":"398","author":"P Prabutzki","year":"2024","unstructured":"Prabutzki, P., Schiller, J. & Engel, K. M. Phospholipid-derived lysophospholipids in (patho)physiology. Atherosclerosis 398, 118569 (2024).","journal-title":"Atherosclerosis"},{"key":"40864_CR37","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1161\/ATVBAHA.111.234096","volume":"31","author":"PJ Meikle","year":"2011","unstructured":"Meikle, P. J. et al. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler. Thromb. Vasc Biol. 31, 2723\u20132732 (2011).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"40864_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cca.2014.07.024","volume":"437","author":"M Nishimukai","year":"2014","unstructured":"Nishimukai, M. et al. Serum choline plasmalogens-those with oleic acid in sn-2-are biomarkers for coronary artery disease. Clin. Chim. Acta. 437, 147\u2013154 (2014).","journal-title":"Clin. Chim. Acta"},{"key":"40864_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.plipres.2011.02.004","volume":"50","author":"M Hermansson","year":"2011","unstructured":"Hermansson, M., Hokynar, K. & Somerharju, P. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog Lipid Res. 50, 240\u2013257 (2011).","journal-title":"Prog Lipid Res."},{"key":"40864_CR40","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2174\/092986709788682164","volume":"16","author":"J Lessig","year":"2009","unstructured":"Lessig, J. & Fuchs, B. Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Curr. Med. Chem. 16, 2021\u20132041 (2009).","journal-title":"Curr. Med. Chem."},{"key":"40864_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.chemphyslip.2011.06.008","volume":"164","author":"S Wallner","year":"2011","unstructured":"Wallner, S. & Schmitz, G. Plasmalogens the neglected regulatory and scavenging lipid species. Chem. Phys. Lipids. 164, 573\u2013589 (2011).","journal-title":"Chem. Phys. Lipids"},{"key":"40864_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","volume":"9","author":"JM Dean","year":"2018","unstructured":"Dean, J. M. & Lodhi, I. J. Structural and functional roles of ether lipids. Protein Cell. 9, 196\u2013206 (2018).","journal-title":"Protein Cell."},{"key":"40864_CR43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","volume":"1831","author":"JE Vance","year":"2013","unstructured":"Vance, J. E. & Tasseva, G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim. Biophys. Acta. 1831, 543\u2013554 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"40864_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","volume":"321","author":"E Calzada","year":"2016","unstructured":"Calzada, E., Onguka, O. & Claypool, S. M. Phosphatidylethanolamine Metabolism in Health and Disease. Int. Rev. Cell. Mol. Biol. 321, 29\u201388 (2016).","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"40864_CR45","first-page":"2003","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo, C., Sun, L., Chen, X. & Zhang, D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 8, 2003\u20132014 (2013).","journal-title":"Neural Regen Res."},{"key":"40864_CR46","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/cdd.2014.219","volume":"22","author":"P Rockenfeller","year":"2015","unstructured":"Rockenfeller, P. et al. Phosphatidylethanolamine positively regulates autophagy and longevity. Cell. Death Differ. 22, 499\u2013508 (2015).","journal-title":"Cell. Death Differ."},{"key":"40864_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41420-024-02224-8","volume":"10","author":"M Jarocki","year":"2024","unstructured":"Jarocki, M., Turek, K., Saczko, J., Tarek, M. & Kulbacka, J. Lipids associated with autophagy: Mechanisms and therapeutic targets. Cell. Death Discov. 10, 460 (2024).","journal-title":"Cell. Death Discov"},{"key":"40864_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2020.04.008","volume":"302","author":"W Pan","year":"2020","unstructured":"Pan, W. et al. Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction. Atherosclerosis 302, 8\u201314 (2020).","journal-title":"Atherosclerosis"},{"key":"40864_CR49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2007.09.018","volume":"196","author":"J Bismuth","year":"2008","unstructured":"Bismuth, J., Lin, P., Yao, Q. & Chen, C. Ceramide: a common pathway for atherosclerosis? Atherosclerosis 196, 497\u2013504 (2008).","journal-title":"Atherosclerosis"},{"key":"40864_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbalip.2005.05.004","volume":"1735","author":"Z Li","year":"2005","unstructured":"Li, Z. et al. The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis. Biochim. Biophys. Acta. 1735, 130\u2013134 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"40864_CR51","doi-asserted-by":"publisher","first-page":"232","DOI":"10.14336\/AD.2021.0710","volume":"13","author":"H Shu","year":"2022","unstructured":"Shu, H. et al. Emerging Roles of Ceramide in Cardiovascular Diseases. Aging Dis. 13, 232\u2013245 (2022).","journal-title":"Aging Dis."},{"key":"40864_CR52","doi-asserted-by":"crossref","unstructured":"He, X. & Schuchman, E. H. Ceramide and Ischemia\/Reperfusion Injury. J. Lipids. 3646725 2018 (2018).","DOI":"10.1155\/2018\/3646725"},{"key":"40864_CR53","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/FJC.0b013e31819b52d5","volume":"53","author":"SA Novgorodov","year":"2009","unstructured":"Novgorodov, S. A. & Gudz, T. I. Ceramide and mitochondria in ischemia\/reperfusion. J. Cardiovasc. Pharmacol. 53, 198\u2013208 (2009).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"40864_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/01.RES.86.2.198","volume":"86","author":"OM Hernandez","year":"2000","unstructured":"Hernandez, O. M., Discher, D. J., Bishopric, N. H. & Webster, K. A. Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes. Circ. Res. 86, 198\u2013204 (2000).","journal-title":"Circ. Res."},{"key":"40864_CR55","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon, C. P. et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl. J. Med. 372, 2387\u20132397 (2015).","journal-title":"N Engl. J. Med."},{"key":"40864_CR56","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl. J. Med. 359, 2195\u20132207 (2008).","journal-title":"N Engl. J. Med."},{"key":"40864_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/35036052","volume":"1","author":"K Simons","year":"2000","unstructured":"Simons, K. & Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 1, 31\u201339 (2000).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"40864_CR58","doi-asserted-by":"publisher","first-page":"132698","DOI":"10.1016\/j.ijcard.2024.132698","volume":"419","author":"B Gigante","year":"2025","unstructured":"Gigante, B. et al. Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis. Int. J. Cardiol. 419, 132698 (2025).","journal-title":"Int. J. Cardiol."},{"key":"40864_CR59","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1172\/JCI0216421","volume":"110","author":"JK Liao","year":"2002","unstructured":"Liao, J. K. Isoprenoids as mediators of the biological effects of statins. J. Clin. Invest. 110, 285\u2013288 (2002).","journal-title":"J. Clin. Invest."},{"key":"40864_CR60","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1073\/pnas.0500269102","volume":"102","author":"M Garcia-Calvo","year":"2005","unstructured":"Garcia-Calvo, M. et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc. Natl. Acad. Sci. 102, 8132\u20138137 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"40864_CR61","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1194\/jlr.M009449","volume":"51","author":"O Quehenberger","year":"2010","unstructured":"Quehenberger, O. et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51, 3299\u20133305 (2010).","journal-title":"J. Lipid Res."},{"key":"40864_CR62","doi-asserted-by":"publisher","first-page":"119892","DOI":"10.1016\/j.cca.2024.119892","volume":"562","author":"C Guo","year":"2024","unstructured":"Guo, C. et al. Lipidomic analyses reveal potential biomarkers for predicting death and heart failure after acute myocardial infarction. Clin. Chim. Acta. 562, 119892 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"40864_CR63","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.3390\/ijms24043291","volume":"24","author":"E Gianazza","year":"2023","unstructured":"Gianazza, E., Brioschi, M., Iezzi, A., Paglia, G. & Banfi, C. Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges. Int. J. Mol. Sci. 24, 3291 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"40864_CR64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/metabo10040163","volume":"10","author":"M Ding","year":"2020","unstructured":"Ding, M. & Rexrode, K. M. A review of lipidomics of cardiovascular disease highlights the importance of isolating lipoproteins. Metabolites 10, 163 (2020).","journal-title":"Metabolites"},{"key":"40864_CR65","doi-asserted-by":"publisher","first-page":"15973","DOI":"10.1038\/s41598-021-95455-z","volume":"11","author":"A Klassen","year":"2021","unstructured":"Klassen, A. et al. Evaluation of two highly effective lipid-lowering therapies in subjects with acute myocardial infarction. Sci. Rep. 11, 15973 (2021).","journal-title":"Sci. Rep."},{"key":"40864_CR66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jchromb.2013.10.029","volume":"944","author":"JM Choi","year":"2014","unstructured":"Choi, J. M., Kim, T. E., Cho, J. Y., Lee, H. J. & Jung, B. H. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 944, 157\u2013165 (2014).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"40864_CR67","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/ATVBAHA.121.317513","volume":"42","author":"CCF Tam","year":"2022","unstructured":"Tam, C. C. F. et al. Multi-omics signatures link to ticagrelor effects on vascular function in patients with acute coronary syndrome. Arterioscler. Thromb. Vasc Biol. 42, 789\u2013798 (2022).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"40864_CR68","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1055\/s-0038-1648083","volume":"36","author":"J Valles","year":"1976","unstructured":"Valles, J., Aznar, J. & Santos, M. T. Effect of aspirin on platelet phospholipids. Thromb. Haemost. 36, 628\u2013633 (1976).","journal-title":"Thromb. Haemost"},{"key":"40864_CR69","first-page":"1891","volume":"34","author":"A Majid","year":"2021","unstructured":"Majid, A. et al. Effect of nebivolol beneficial on lipid profile and glycemic control in comparison with Atenolol in patients with type 2 DM with concomitant hypertension. Pak J. Pharm. Sci. 34, 1891\u20131895 (2021).","journal-title":"Pak J. Pharm. Sci."},{"key":"40864_CR70","first-page":"57","volume":"4","author":"H Drexel","year":"2001","unstructured":"Drexel, H., Schmid, H. R., Follath, F. & Amann, F. W. Effects of bisoprolol on lipoprotein cholesterol subfractions and apolipoproteins in patients with hypertension. J. Clin. Basic. Cardiol. 4, 57\u201360 (2001).","journal-title":"J. Clin. Basic. Cardiol."},{"key":"40864_CR71","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 107, 1058\u20131070 (2010).","journal-title":"Circ. Res."},{"key":"40864_CR72","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.jacc.2009.02.041","volume":"53","author":"AE Fraley","year":"2009","unstructured":"Fraley, A. E. et al. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J. Am. Coll. Cardiol. 53, 2186\u20132196 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"40864_CR73","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.116.023233","volume":"134","author":"ZH Alshehry","year":"2016","unstructured":"Alshehry, Z. H. et al. Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus. Circulation 134, 1637\u20131650 (2016).","journal-title":"Circulation"},{"key":"40864_CR74","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.bbrc.2018.04.106","volume":"504","author":"S Kohno","year":"2018","unstructured":"Kohno, S., Keenan, A. L., Ntambi, J. M. & Miyazaki, M. Lipidomic insight into cardiovascular diseases. Biochem. Biophys. Res. Commun. 504, 590\u2013595 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"40864_CR75","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","volume":"129","author":"C Stegemann","year":"2014","unstructured":"Stegemann, C. et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 129, 1821\u20131831 (2014).","journal-title":"Circulation"},{"key":"40864_CR76","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/ATVBAHA.121.316847","volume":"42","author":"SH Tan","year":"2022","unstructured":"Tan, S. H. et al. Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis. Arterioscler. Thromb. Vasc Biol. 42, 100\u2013112 (2022).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"40864_CR77","doi-asserted-by":"publisher","first-page":"12899","DOI":"10.1038\/s41598-021-92339-0","volume":"11","author":"E Michelucci","year":"2021","unstructured":"Michelucci, E. et al. Lipid biomarkers in statin users with coronary artery disease annotated by coronary computed tomography angiography. Sci. Rep. 11, 12899 (2021).","journal-title":"Sci. Rep."},{"key":"40864_CR78","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jcin.2017.04.007","volume":"10","author":"S Cui","year":"2017","unstructured":"Cui, S. et al. Plasma phospholipids and sphingolipids identify stent restenosis after percutaneous coronary intervention. JACC Cardiovasc. Interv. 10, 1307\u20131316 (2017).","journal-title":"JACC Cardiovasc. Interv"},{"key":"40864_CR79","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/eurjpc\/zwaa143","volume":"29","author":"B Gencer","year":"2022","unstructured":"Gencer, B. et al. Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome. Eur. J. Prev. Cardiol. 29, 895\u2013902 (2022).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"40864_CR80","doi-asserted-by":"publisher","first-page":"e14359","DOI":"10.1111\/eci.14359","volume":"55","author":"A Witoslawska","year":"2025","unstructured":"Witoslawska, A. et al. Ceramide and phosphatidylcholine lipids-based risk score predicts major cardiovascular outcomes in patients with heart failure. Eur. J. Clin. Invest. 55, e14359 (2025).","journal-title":"Eur. J. Clin. Invest."},{"key":"40864_CR81","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jacl.2022.02.001","volume":"16","author":"AS Papazoglou","year":"2022","unstructured":"Papazoglou, A. S. et al. CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis. J. Clin. Lipidol. 16, 272\u2013276 (2022).","journal-title":"J. Clin. Lipidol."},{"key":"40864_CR82","doi-asserted-by":"publisher","first-page":"117274","DOI":"10.1016\/j.atherosclerosis.2023.117274","volume":"384","author":"R Tabassum","year":"2023","unstructured":"Tabassum, R., Wid\u00e9n, E. & Ripatti, S. Effect of biological sex on human circulating lipidome: An overview of the literature. Atherosclerosis 384, 117274 (2023).","journal-title":"Atherosclerosis"},{"key":"40864_CR83","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ahj.2016.09.012","volume":"183","author":"Y Lu","year":"2017","unstructured":"Lu, Y. et al. Sex differences in lipid profiles and treatment utilization among young adults with acute myocardial infarction: Results from the VIRGO study. Am. Heart J. 183, 74\u201384 (2017).","journal-title":"Am. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40864-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:12:41Z","timestamp":1774433561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40864-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40864"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40864-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9916"}}